p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Histopathology

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2559.2005.02249.xPMID 16241993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship between p63 and p53 expression in normal and neoplastic breast tissue.

  2009cited by this paper
• Is p63 reliable in detecting microinvasion in ductal carcinomain situ of the breast?

  2009cited by this paper
• The prognostic implication of the basal-like (cyclin Ehigh/ p27low/p53+glomeruloid-microvascular-proliferation +) phenotype of BRCA1-related breast cancer

  2005influential reference
• Invasive breast carcinoma

  2005cited by this paper
• Expression of luminal and basal cytokeratins in human breast carcinoma

  2004cited by this paper
• p63 expression in benign and malignant breast lesions.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• p63: Molecular complexity in development and cancer.

  2004cited by this paper
• Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast Cancer

  2004cited by this paper
• BRCA1 functions as a breast stem cell regulator

  2004cited by this paper
• p63 Expression in Lung Carcinoma: A Tissue Microarray Study of 408 Cases

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables.

  2003cited by this paper
• The usefulness of p63 as a marker of breast myoepithelial cells.

  2003cited by this paper
• Distribution of p63, a novel myoepithelial marker, in fine‐needle aspiration biopsies of the breast

  2003cited by this paper
• Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

  2003cited by this paper
• p73 and p63 protein stability: the way to regulate function?

  2003cited by this paper
• Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray

  2003cited by this paper
• Common Adult Stem Cells in the Human Breast Give Rise to Glandular and Myoepithelial Cell Lineages: A New Cell Biological Concept

  2002influential reference
• Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell Marker

  2002cited by this paper
• Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries.

  2002cited by this paper
• p63 expression profiles in human normal and tumor tissues.

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• P63 expression in normal, hyperplastic and malignant breast tissues

  2002cited by this paper
• Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis

  2002cited by this paper
• p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• Expression of cell cycle–regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein‐1 family members

  2000influential reference
• Molecular portraits of human breast tumours

  2000cited by this paper
• p63 is a prostate basal cell marker and is required for prostate development.

  2000cited by this paper
• Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

  1998cited by this paper
• [Prognostic factors in breast cancer].

  1998cited by this paper
• A new human p53 homologue

  1998cited by this paper
• Cloning and functional analysis of human p51, which structurally and functionally resembles p53

  1998cited by this paper
• p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

  1998cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper
• Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

  year unknowncited by this paper

• p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer

  2021cites this paper
• Is it time to include p40 as a standard myoepithelial marker of breast? A comparative study of expression of p63 and p40 in benign breast diseases and invasive ductal carcinomas of the breast

  2021cites this paper
• TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis

  2020cites this paper
• The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine

  2019cites this paper
• p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival

  2018cites this paper
• Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance

  2017cites this paper
• PUBLISHED VERSION

  2017cites this paper
• Breast Cancer Subtypes: Morphologic and Biologic Characterization

  2016cites this paper
• Characterization of P-Cadherin in feline mammary tumours - Association with tumours aggressiveness

  2016influential citation
• p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer

  2016cites this paper
• ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor‐positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines

  2016cites this paper
• Clinical performance of diagnostic, prognostic and predictive immunohistochemical biomarkers for hormone receptor-negative breast cancer

  2015cites this paper
• Isolated Rat Epididymal Basal Cells Share Common Properties with Adult Stem Cells1

  2015cites this paper
• Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.

  2015cites this paper
• Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation

  2014cites this paper
• Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.

  2014cites this paper
• Assessment of DNA-damage repair in breast cancer

  2014cites this paper
• The Role of BRCA1 in Suppressing Epithelial Mesenchymal Transition in Mammary Gland and Tumor Development

  2014cites this paper
• p 40 ( ΔNp 63 ) expression in breast disease and its correlation with p 63 immunohistochemistry

  2014cites this paper
• Evaluation of the diagnostic role of p63 immunostaining in aspiration cytology by smear or cell block preparation for the characterisation of breast lesions.

  2014cites this paper
• THE ROLE OF GERMLINE BRCA1 FOUNDER MUTATIONS AND SOMATIC TP53 MUTATIONS IN THE TRIPLE-NEGATIVE BREAST CANCER SUBTYPE

  2014cites this paper
• p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.

  2014cites this paper
• ΔNP63α Transcriptionally Activates Chemokine Receptor 4 (CXCR4) Expression to Regulate Breast Cancer Stem Cell Activity and Chemotaxis

  2014cites this paper
• Characteristics of basal cytokeratin expression in breast cancer

  2013cites this paper
• A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard

  2013cites this paper
• withrespecttogeneexpressionprofiling(GEP)anditsabilitytodefine thecelloforiginincancersofunknown/uncertainorigin,asdescribed

  2013cites this paper
• Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation

  2013cites this paper
• Molecular classification of breast cancer: An overview with emphasis on ethnic variations and future perspectives

  2013cites this paper
• p53 in the Clinic: A Pathologist’s View

  2013cites this paper
• Reply to R. Bhargava et al and F.A. Greco.

  2013cites this paper
• Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup

  2013cites this paper
• Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.

  2012cites this paper
• [Expression of cytokeratins 5/6 and cytokeratin 17 in invasive breast carcinoma].

  2012cites this paper
• BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype

  2012cites this paper
• Inference of the Basal Epithelial Phenotype in Breast Carcinoma from Differential Marker Expression, Using Tissue Microarrays in Triple Negative Breast Cancer and Women Younger than 35

  2012cites this paper
• Investigating the therapeutic potential of targeting NF-kappaB p52 in pre-clinical models of breast cancer.

  2012cites this paper
• Generation of an oncolytic adenovirus vector combining three cancer targeting strategies and characterization of a new preclinical model for breast cancer virotherapy

  2012cites this paper
• Ekspresija citokeratina 5/6 i citokeratina 17 u invazivnom karcinomu dojke

  2012cites this paper
• Molecular insights on basal-like breast cancer

  2012cites this paper
• Cell adhesion and communication proteins are differentially expressed in melanoma progression model.

  2011cites this paper
• Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer

  2011cites this paper
• Subtipos moleculares do câncer de mama

  2011cites this paper
• Basal Phenotype Breast Cancer: Implications for Treatment and Prognosis

  2011cites this paper
• The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.

  2011cites this paper
• Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea.

  2011cites this paper
• Evaluation of Carcinogenic Potential of Diuron in a Rat Mammary Two-Stage Carcinogenesis Model

  2011cites this paper
• Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays.

  2011cites this paper
• Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.

  2011cites this paper
• Clinical relevance of the putative stem cell marker p63 in breast cancer

  2010cites this paper
• Basal-like subtype of breast carcinoma : An enigmatic group of tumors

  2010cites this paper
• Molecular markers in breast carcinoma. A study with focus on molecular phenotypes, angiogenesis and stem cells in an African population

  2010cites this paper
• Biomarkers for Basal-like Breast Cancer

  2010cites this paper
• Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.

  2010cites this paper
• Basal-Like Immunophenotype Markers and Prognosis in Early Breast Cancer

  2010cites this paper
• Synergistic chemosensitivity of triple-negative breast cancer cell lines to PARP inhibition, gemcitabine and cisplatin

  2010cites this paper
• Cancer esearch apeutics , Targets , and Chemical Biology ergistic Chemosensitivity of Triple-Negative Breast cer Cell Lines to Poly ( ADP-Ribose ) Polymerase R bition , Gemcitabine , and Cisplatin

  2010cites this paper
• Transcription Cofactor LBH is a Direct Target of the Oncogenic WNT Pathway with an Important Role in Breast Cancer

  2010cites this paper
• Tumor marker phenotype concordance in second primary breast cancer, California, 1999–2004

  2010cites this paper
• Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway

  2010cites this paper
• Basal-like breast carcinoma: from expression profiling to routine practice.

  2009cites this paper
• A Rapid Double Immunostaining Technique with a Single Cocktail of CK5, CK14, p63, CK7 and CK18 Distinguishes Between Hyperplasia of the Usual Type, Atypical Hyperplasia, Microinvasive and Basal Phenotype Breast Cancers

  2009cites this paper
• Cadmium Malignantly Transforms Normal Human Breast Epithelial Cells into a Basal-like Phenotype

  2009cites this paper
• Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity

  2009cites this paper
• Triple-Negative Breast Carcinoma.

  2009cites this paper
• From Expression Profiling to Routine Practice

  2009cites this paper
• ASSOCIATION OF GENETIC AND NON-GENETIC RISK FACTORS WITH SPECIFIC BRCA MUTATION POSITIVE BREAST CANCERS IN SOME PAKISTANI FEMALES

  2009cites this paper
• The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma

  2009cites this paper
• Triple‐negative/basal‐like breast cancer: review

  2009cites this paper
• Patho-biological aspects of basal-like breast cancer

  2009cites this paper
• BENIGN AND MALIGNANT MYOEPITHELIOMAS IN SALIVARY GLAND: CASES REPORT AND IMMUNOHISTOCHEMICAL STUDY

  2009cites this paper
• Molekulare Pathologie beim Mammakarzinom

  2009cites this paper
• Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.

  2009cites this paper
• TRIPLE- NEGATIVE CARCINOMA

  2009cites this paper
• Osteopontin expression according to molecular profile of invasive breast cancer: a clinicopathological and immunohistochemical study.

  2008cites this paper
• Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.

  2008cites this paper
• The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

  2008cites this paper
• Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients.

  2008cites this paper
• Delineating the epithelial hierarchy in the mouse mammary gland.

  2008cites this paper
• Basal-like breast cancer: a critical review.

  2008cites this paper
• Morphological and immunophenotypic analysis of basal-like carcinoma of the breast

  2008cites this paper
• Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

  2008cites this paper
• Clasificación molecular del cáncer de mama

  2008cites this paper
• [Molecular classification of breast cancer].

  2008cites this paper
• Clinical and pathologic aspects of basal-like breast cancers

  2008cites this paper
• Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

  2008cites this paper
• Expression of apoptosis-related protein Bcl-2 correlates with breast carcinomas of luminal or basal-like subtype

  2008cites this paper
• Regulation of the transcription factor p63 by [beta]TrCP

  2008cites this paper
• Osteopontin Expression According to Molecular Profile of Invasive Breast Cancer: A Clinicopathological and Immunohistochemical Study

  2008cites this paper
• Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas

  2008cites this paper
• BRCA1 dysfunction in sporadic basal-like breast cancer

  2007cites this paper
• Giant Apocrine Hidradenoma of the Breast

  2007cites this paper
• p63: The Phantom of the Tumor Suppressor

  2007cites this paper
• p63 – from expression to function : studies of normal oral mucosa and squamous cell carcinoma of the head and neck

  2007cites this paper
• Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.

  2007cites this paper
• Basal-like breast cancers

  2007cites this paper
• The Phenotypic Spectrum of Basal-like Breast Cancers: A Critical Appraisal

  2007cites this paper
• Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice

  2007cites this paper
• P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma.

  2007cites this paper
• Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

  2007cites this paper
• What can breast cancer molecular sub-classification add to conventional diagnostic tools?

  2007cites this paper